QQ客服 官方微博 反馈留言

	Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients
	Qian Chenyue; Zheng Yi; Wang Ying; Chen Juan; Liu Junyan; Zhou Honghao; Yin Jiye; Liu Zhaoqian
刊名	Chinese Journal of Cancer
	2016
卷号	35期号:1页码:604-616
关键词	OCT2 MATE1 ABCC2 Non-small cell lung cancer Platinum-based chemotherapy
ISSN号	1000-467X
DOI	10.1186/s40880-016-0145-8
URL标识	查看原文
WOS记录号	WOS:000382816100001;PMID:27590272
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3342376
专题	中南大学
作者单位	1.[Qian Chenyue 2.Yin Jiye 3.Liu Zhaoqian 4.Zhou Honghao 5.Chen Juan] Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha 410008, Hunan, Peoples R China.
推荐引用方式 GB/T 7714	Qian Chenyue,Zheng Yi,Wang Ying,et al. Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients[J]. Chinese Journal of Cancer,2016,35(1):604-616.
APA	Qian Chenyue.,Zheng Yi.,Wang Ying.,Chen Juan.,Liu Junyan.,...&Liu Zhaoqian.(2016).Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients.Chinese Journal of Cancer,35(1),604-616.
MLA	Qian Chenyue,et al."Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients".Chinese Journal of Cancer 35.1(2016):604-616.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。